Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00262223 · ClinicalTrials.gov registry record · Phase 2
Combined Treatment for Alcohol-Dependent Individuals With PTSD
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 69
- Enrollment target
NCT00262223 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 69 participants.
The verdict
NCT00262223, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 69 participants
- Enrollment target
Study Summary
This treatment intervention trial is designed for men and women with either alcohol misuse (e.g. hazardous or binge drinking) or alcohol use disorders (alcohol abuse or dependence) and comorbid PTSD. Participants will be randomly assigned to one of two treatments (a cognitive behavioral treatment intervention called "Seeking Safety" + Medication ("Zoloft") or Seeking Safety + placebo) and will be evaluated at baseline, at completion of the treatment (12 sessions over 12 weeks), and again at 6 months and 12 months post-treatment.
Interventions
- DRUG Sertraline
- BEHAVIORAL Seeking Safety
- DRUG Pill placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2006-05 |
| Est. Completion | 2013-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00262223
The ClinicalTrials.gov registry entry for NCT00262223 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sertraline is the first listed.
NCT00262223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00262223 about?
NCT00262223 is a clinical study titled "Combined Treatment for Alcohol-Dependent Individuals With PTSD". This treatment intervention trial is designed for men and women with either alcohol misuse (e.g. hazardous or binge drinking) or alcohol use disorders (alcohol abuse or dependence) and comorbid PTSD. Participants will be randomly assigned to one of two treatments (a cognitive behavioral treatment in...
What is the current status of trial NCT00262223?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2006-05. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00262223?
The interventions under investigation include: Sertraline (DRUG), Seeking Safety (BEHAVIORAL), Pill placebo (DRUG).
Who is sponsoring clinical trial NCT00262223?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.